Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Notable Labs, Ltd. (NTBLQ) vs Oragenics, Inc. (OGEN)

Notable Labs, Ltd. and Oragenics, Inc. are both Biotechnology companies. Notable Labs, Ltd. and Oragenics, Inc. are of similar size ($2.4M and $2.3M). Notable Labs, Ltd. has negative trailing earnings, so its P/E is not meaningful; Oragenics, Inc. trades at 0.4×. Oragenics, Inc. grew revenue faster over the last twelve months: −75.1% against −129.0%. Notable Labs, Ltd. has the higher net margin (6,350.6% vs 0.00%) and the lower return on invested capital (−295.4% vs 0.00%). Across the 17 metrics below, Notable Labs, Ltd. leads on 9 and Oragenics, Inc. on 8.

Valuation

Metric NTBLQ OGEN Biotechnology median
P/E n/m 0.44 7.88
P/S n/m 17.54 11.47
P/B n/m 0.59 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.25 0.16 0.74
EV/Sales 23.30 (13.16) 10.73
Earnings yield 0.00% 228.10% (28.84%)
Free cash flow yield 0.00% (469.27%) (23.03%)

Profitability

Metric NTBLQ OGEN Biotechnology median
Gross margin 116.87% 19.89% 65.16%
Operating margin 9,259.04% 0.00% 0.00%
Net margin 6,350.60% 0.00% 0.00%
Free cash flow margin 9,158.43% 0.00% 0.00%
Return on equity (79.79%) (1,307.07%) (57.72%)
Return on assets (59.14%) (264.23%) (49.22%)
Return on invested capital (295.36%) 0.00% 0.00%

Growth

Metric NTBLQ OGEN Biotechnology median
Revenue growth (TTM) (129.02%) (75.08%) 5.64%
EPS growth (last fiscal year) 84.47% 90.51% —
Revenue growth, 5-year CAGR (11.93%) (50.98%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NTBLQ OGEN Biotechnology median
Debt to equity 0.03 0.00 0.00
Current ratio 2.77 3.01 4.73
Net debt to EBITDA 0.80 0.98 0.96

Dividend

Metric NTBLQ OGEN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric NTBLQ OGEN Biotechnology median
Market cap 2.39m 2.27m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack